|27.57||+0.12 / +0.44%|
Data as of 3:59pm ET
|26.85||-0.72 / -2.61%|
The 6 analysts offering 12-month price forecasts for ACADIA Pharmaceuticals Inc have a median target of 32.00, with a high estimate of 46.00 and a low estimate of 26.00. The median estimate represents a +16.07% increase from the last price of 27.57.
The current consensus among 6 polled investment analysts is to Buy stock in ACADIA Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.